Phase III data presented at the ESMO 2014 Congress in Madrid, Spain reveals that a new drug called anamorelin, improves appetite and body mass in patients with advanced lung cancer who are suffering cancer anorexia. "Anorexia and cachexia are among the most troubling and distressing symptoms of advanced cancer, for both patients and their families," says the study's principal investigator, Dr Jennifer Temel from the Department of Medicine, Massachusetts General ...
via Medindia Health News
More READ 
Lake forest health and fitness http://ift.tt/1nohNju
No comments:
Post a Comment